HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christian Eckmann Selected Research

Intraabdominal Infections

1/2020Calculated parenteral initial treatment of bacterial infections: Intra-abdominal infections.
1/2019Influence of age on the clinical efficacy of tigecycline in severely ill patients.
1/2019Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI).
8/2016Evaluation of Tigecycline Efficacy and Post-Discharge Outcomes in a Clinical Practice Population with Complicated Intra-Abdominal Infection: A Propensity Score-Matched Analysis.
1/2016Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).
5/2015Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI).
2/2015Ceftolozane/tazobactam for the treatment of complicated intra-abdominal infections.
12/2013A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts.
7/2013Resistance mechanisms and epidemiology of multiresistant pathogens in Europe and efficacy of tigecycline in observational studies.
7/2013Safety and tolerability of tigecycline for the treatment of complicated skin and soft-tissue and intra-abdominal infections: an analysis based on five European observational studies.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christian Eckmann Research Topics

Disease

17Infections
12/2023 - 11/2010
14Soft Tissue Infections
12/2023 - 11/2010
14Intraabdominal Infections
01/2020 - 01/2011
6Critical Illness (Critically Ill)
10/2015 - 01/2011
5Sepsis (Septicemia)
12/2019 - 02/2009
3Peritonitis
11/2022 - 03/2019
3Communicable Diseases (Infectious Diseases)
10/2018 - 03/2011
2Wound Infection (Wound Infections)
12/2023 - 10/2012
2Septic Shock (Toxic Shock Syndrome)
12/2019 - 03/2019
2Inflammation (Inflammations)
12/2019 - 03/2019
2Cross Infection (Nosocomial Infection)
07/2013 - 07/2013
2Hemorrhage
10/2012 - 10/2002
1Surgical Wound Infection
01/2024
1Heart Failure
12/2019
1Liver Failure
12/2019
1Malnutrition (Nutritional Deficiencies)
12/2019
1Multiple Organ Failure (MODS)
03/2019
1Necrosis
03/2019
1Cellulitis
03/2019
1Shock
03/2019
1Neoplasms (Cancer)
01/2016
1Candidiasis (Moniliasis)
12/2013
1Anastomotic Leak
12/2013
1Clostridium Infections
10/2013
1Paralysis (Palsy)
10/2012
1Diabetic Foot
11/2010
1Coinfection
11/2010
1Bacteremia
11/2010
1Diabetes Mellitus
04/2009
1Renal Insufficiency (Renal Failure)
04/2009
1Fournier Gangrene
02/2009
1Wounds and Injuries (Trauma)
02/2009
1Body Weight (Weight, Body)
10/2002

Drug/Important Bio-Agent (IBA)

20Anti-Bacterial Agents (Antibiotics)IBA
01/2024 - 11/2010
11Tigecycline (Tygacil)FDA Link
01/2019 - 11/2010
3Carbapenems (Carbapenem Antibiotics)IBA
12/2019 - 07/2013
3tazobactam drug combination ceftolozaneIBA
01/2019 - 02/2015
2Meropenem (Merrem)FDA LinkGeneric
01/2019 - 05/2015
2Methicillin (Metin)FDA Link
07/2014 - 07/2013
1LipoglycopeptidesIBA
11/2021
1FluoroquinolonesIBA
11/2021
1Clindamycin (Cleocin)FDA LinkGeneric
01/2021
1Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
01/2021
1beta-Lactamases (beta-Lactamase)IBA
12/2019
1Immunoglobulins (Immunoglobulin)IBA
03/2019
1Biomarkers (Surrogate Marker)IBA
03/2019
1HLA-DR Antigens (HLA-DR)IBA
03/2019
1Bacterial ToxinsIBA
03/2019
1ceftazidime drug combination avibactamIBA
01/2019
1Keratins (Keratin)IBA
01/2016
1Caspase 3 (Caspase-3)IBA
01/2016
1Metronidazole (Metric)FDA LinkGeneric
05/2015
1ProcalcitoninIBA
12/2013
1EchinocandinsIBA
12/2013
1LipidsIBA
12/2013
1Fluconazole (Zonal)FDA LinkGeneric
12/2013
1AzolesIBA
12/2013
1Amphotericin B (Amphotericin)FDA LinkGeneric
12/2013
1Third Generation CephalosporinsIBA
07/2013
1GlycopeptidesIBA
07/2013
1VancomycinFDA LinkGeneric
11/2010
1DaptomycinFDA Link
11/2010
1Linezolid (Zyvox)FDA Link
11/2010
1C-Reactive ProteinIBA
04/2009
1reviparin (reviparin-sodium)IBA
10/2002
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
10/2002

Therapy/Procedure

15Therapeutics
11/2022 - 02/2009
4Debridement
03/2019 - 02/2009
3Critical Care (Surgical Intensive Care)
12/2013 - 03/2011
2Length of Stay
10/2013 - 10/2012
1Antibiotic Prophylaxis
04/2024
1Catheters
12/2023
1Heart-Assist Devices
12/2023
1Play Therapy (Therapy, Play)
01/2020
1Precision Medicine
03/2019
1Drug Therapy (Chemotherapy)
01/2016
1Ligation
10/2012
1Negative-Pressure Wound Therapy
02/2009